The sector needs to clean up its act and focus on quality. It won’t until New Delhi insists on more and better regulations.

According to the report, titled "India Bioeconomy Report 2025", the bioeconomy sector witnessed a 16-fold expansion in the ...

The e-commerce sector in India is expected to witness the highest salary hike in 2025, with hikes surpassing 10%, said a ...

Tariffs on Indian generics could raise US drug prices, disrupt supply chains, and strain insurance systems. Indian firms, ...

The Board of Investment highlighted Thailand’s strategic advantages as it seeks to position itself as a regional hub for high ...

Mumbai: Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a ...

India has reported eight outbreaks of highly pathogenic H5N1 bird flu in farms and backyard poultry, the World Organisation ...

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan ...

India has emerged as a growing player in the illicit fentanyl trade, a new US intelligence report says, a designation likely ...

The Food and Drug Administration has found problems at an Indian factory that makes generic drugs for American patients, ...

Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...

With its active pharmaceutical ingredient (API) facility “in a state of disrepair,” manufacturer Aspen Biopharma Labs’ operations have ground to a halt in the U.S., according to a recent FDA reprim | ...